L. M. Walker, S. K. Phogat, C. Hui, P. Y. Wagner, D. Phung et al., Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target, Science, vol.326, issue.5950, pp.285-294, 2009.

J. F. Scheid, H. Mouquet, N. Feldhahn, M. S. Seaman, and K. Velinzon, Broad diversity of neutralizing antibodies isolated from memory B cells in HIVinfected individuals, Nature, vol.458, issue.7238, pp.636-676, 2009.

X. Wu, Z. Y. Yang, Y. Li, C. M. Hogerkorp, and W. R. Schief, Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1, Science, vol.329, issue.5993, pp.856-61, 2010.

T. Zhou, I. Georgiev, X. Wu, Z. Y. Yang, and K. Dai, Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01, Science, vol.329, issue.5993, pp.811-818, 2010.

D. Corti, J. P. Langedijk, A. Hinz, M. S. Seaman, and F. Vanzetta, Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals, PLoS One, vol.5, issue.1, p.8805, 2010.

J. F. Scheid, H. Mouquet, B. Ueberheide, R. Diskin, and F. Klein, Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding, Science, vol.333, issue.6049, pp.1633-1640, 2011.

X. Wu, T. Zhou, J. Zhu, B. Zhang, and I. Georgiev, Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing, Science, vol.333, issue.6049, pp.1593-602, 2011.

L. M. Walker, M. Huber, K. J. Doores, E. Falkowska, and R. Pejchal, Broad neutralization coverage of HIV by multiple highly potent antibodies, Nature, vol.477, issue.7365, pp.466-70, 2011.

J. Huang, G. Ofek, L. Laub, M. K. Louder, and N. A. Doria-rose, Broad and potent neutralization of HIV-1 by a gp41-specific human antibody, Nature, vol.491, issue.7424, pp.406-418, 2012.

P. D. Kwong and J. R. Mascola, Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies. Immunity, vol.37, issue.3, pp.412-425, 2012.

J. M. Kovacs, J. P. Nkolola, H. Peng, A. Cheung, and J. Perry, HIV-1 envelope trimer elicits more potent neutralizing antibody responses than monomeric gp120, Proc Natl Acad Sci, vol.109, issue.30, pp.12111-12117, 2012.

G. Sellhorn, Z. Kraft, Z. Caldwell, K. Ellingson, and C. Mineart, Engineering, expression, purification, and characterization of stable clade A/B recombinant soluble heterotrimeric gp140 proteins, J Virol, vol.86, issue.1, pp.128-170, 2012.

C. Sundling, M. N. Forsell, O. Dell, S. Feng, Y. Chakrabarti et al., Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates, J Exp Med, vol.207, issue.9, pp.2003-2020, 2010.

Y. Feng, K. Mckee, K. Tran, O. Dell, S. Schmidt et al., Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site, J Biol Chem, vol.287, issue.8, pp.5673-86, 2012.

P. D. Kwong, J. R. Mascola, and G. J. Nabel, Rational Design of Vaccines to Elicit Broadly Neutralizing Antibodies to HIV-1. Cold Spring Harb Perspect Med, vol.1, p.7278, 2011.

M. J. Mcelrath and B. F. Haynes, Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination, Immunity, vol.33, issue.4, pp.542-554, 2010.

L. M. Walker and D. R. Burton, Rational antibody-based HIV-1 vaccine design: current approaches and future directions, Current Opinion in Immunology, vol.22, issue.3, pp.358-66, 2010.

W. Weissenhorn, A. Hinz, and Y. Gaudin, Virus membrane fusion, FEBS Lett, vol.581, issue.11, pp.2150-2155, 2007.

S. C. Harrison, Viral membrane fusion, Nat Struct Mol Biol, vol.15, issue.7, pp.690-698, 2008.

T. Muster, F. Steindl, M. Purtscher, A. Trkola, and A. Klima, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, J Virol, vol.67, issue.11, pp.6642-6649, 1993.

G. Stiegler, R. Kunert, M. Purtscher, S. Wolbank, and R. Voglauer, A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Res Hum Retroviruses, vol.17, issue.18, pp.1757-65, 2001.

M. B. Zwick, A. F. Labrijn, M. Wang, C. Spenlehauer, and E. O. Saphire, Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41, J Virol, vol.75, issue.22, pp.10892-905, 2001.

J. D. Nelson, F. M. Brunel, R. Jensen, E. T. Crooks, and R. M. Cardoso, An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10, J Virol, vol.81, issue.8, pp.4033-4076, 2007.

G. Ofek, M. Tang, A. Sambor, H. Katinger, and J. R. Mascola, Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope, J Virol, vol.78, pp.10724-10761, 2004.

R. M. Cardoso, M. B. Zwick, R. L. Stanfield, R. Kunert, and J. M. Binley, Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41, Immunity, vol.22, issue.2, pp.163-73, 2005.

R. Pejchal, J. S. Gach, F. M. Brunel, R. M. Cardoso, and R. L. Stanfield, A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies, J Virol, vol.83, issue.17, pp.8451-8462, 2009.

W. Weissenhorn, A. Dessen, S. C. Harrison, J. J. Skehel, and D. C. Wiley, Atomic structure of the ectodomain from HIV-1 gp41, Nature, vol.387, issue.6631, pp.426-456, 1997.

D. C. Chan, D. Fass, J. M. Berger, and P. S. Kim, Core structure of gp41 from the HIV envelope glycoprotein, Cell, vol.89, issue.2, pp.263-73, 1997.

V. Buzon, G. Natrajan, D. Schibli, F. Campelo, and M. M. Kozlov, Crystal Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions, PLoS Pathog, vol.6, issue.5, p.1000880, 2010.

F. Ferrantelli, R. Hofmann-lehmann, R. A. Rasmussen, T. Wang, and W. Xu, Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques, Aids, vol.17, issue.3, pp.301-309, 2003.

J. R. Mascola, M. G. Lewis, G. Stiegler, D. Harris, and T. C. Vancott, Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies, J Virol, vol.73, issue.5, pp.4009-4027, 1999.

J. R. Mascola, G. Stiegler, T. C. Vancott, H. Katinger, and C. B. Carpenter, Protection of macaques against vaginal transmission of a pathogenic HIV-1/ SIV chimeric virus by passive infusion of neutralizing antibodies, Nat Med, vol.6, issue.2, pp.207-217, 2000.

T. W. Baba, V. Liska, R. Hofmann-lehmann, J. Vlasak, and W. Xu, Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection, Nat Med, vol.6, issue.2, pp.200-206, 2000.

R. Hofmann-lehmann, J. Vlasak, R. A. Rasmussen, B. A. Smith, and T. W. Baba, Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge, J Virol, vol.75, issue.16, pp.7470-80, 2001.

A. J. Hessell, E. G. Rakasz, P. Poignard, L. Hangartner, and G. Landucci, Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers, PLoS Pathog, vol.5, issue.5, p.1000433, 2009.

N. J. Mantis, P. A. Kozlowski, D. W. Mielcarz, W. Weissenhorn, and M. R. Neutra, Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies, Vaccine, vol.19, pp.3990-4001, 2001.

O. Lenz, M. T. Dittmar, A. Wagner, B. Ferko, K. Vorauer-uhl et al., Trimeric membrane-anchored gp41 inhibits HIV membrane fusion, J Biol Chem, vol.280, issue.6, pp.4095-101, 2005.

Z. S. Qiao, M. Kim, B. Reinhold, D. Montefiori, J. H. Wang et al., Design, expression, and immunogenicity of a soluble HIV trimeric envelope fragment adopting a prefusion gp41 configuration, J Biol Chem, vol.280, issue.24, pp.23138-23184, 2005.
DOI : 10.1074/jbc.m414515200
URL : http://www.jbc.org/content/280/24/23138.full.pdf

M. Law, R. M. Cardoso, I. A. Wilson, and D. R. Burton, Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy, J Virol, vol.81, issue.8, pp.4272-85, 2007.
DOI : 10.1128/jvi.02536-06
URL : http://jvi.asm.org/content/81/8/4272.full.pdf

S. Phogat, K. Svehla, M. Tang, A. Spadaccini, and J. Muller, Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles, Virology, vol.373, issue.1, pp.72-84, 2008.

A. Hinz, G. Schoehn, H. Quendler, D. L. Hulsik, and G. Stiegler, Characterization of a trimeric MPER containing HIV-1 gp41 antigen, Virology, vol.390, issue.2, pp.221-228, 2009.
DOI : 10.1016/j.virol.2009.05.015
URL : https://doi.org/10.1016/j.virol.2009.05.015

L. Ye, Z. Wen, K. Dong, X. Wang, and Z. Bu, Induction of HIV Neutralizing Antibodies against the MPER of the HIV Envelope Protein by HA/gp41 Chimeric Protein-Based DNA and VLP Vaccines, PLoS One, vol.6, issue.5, p.14813, 2011.

S. Jain, A. J. Patrick, and K. L. Rosenthal, Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen, Vaccine, vol.28, issue.43, pp.7070-80, 2010.

S. M. Dennison, L. L. Sutherland, F. H. Jaeger, K. M. Anasti, and R. Parks, Induction of antibodies in rhesus macaques that recognize a fusionintermediate conformation of HIV-1 gp41, PLoS One, vol.6, issue.11, p.27824, 2011.

M. Zhou, I. Kostoula, B. Brill, E. Panou, and M. Sakarellos-daitsiotis, Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice. Vaccine, vol.30, pp.1911-1917, 2012.

B. F. Haynes, J. Fleming, S. Clair, E. W. Katinger, H. Stiegler et al., Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies, Science, vol.308, issue.5730, pp.1906-1914, 2005.
DOI : 10.1126/science.1111781

H. Mouquet, J. F. Scheid, M. J. Zoller, M. Krogsgaard, and R. G. Ott, Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation, Nature, vol.467, issue.7315, pp.591-596, 2010.

S. M. Alam, M. Morelli, S. M. Dennison, H. X. Liao, and R. Zhang, Role of HIV membrane in neutralization by two broadly neutralizing antibodies, Proc Natl Acad Sci, vol.106, issue.48, pp.20234-20243, 2009.
DOI : 10.1073/pnas.0908713106
URL : http://www.pnas.org/content/106/48/20234.full.pdf

E. M. Scherer, D. P. Leaman, M. B. Zwick, A. J. Mcmichael, and D. R. Burton, Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions, Proc Natl Acad Sci, vol.107, issue.4, pp.1529-1563, 2010.

G. Ofek, K. Mckee, Y. Yang, Z. Y. Yang, and J. Skinner, Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region, J Virol, vol.84, issue.6, pp.2955-62, 2010.

J. P. Julien, N. Huarte, R. Maeso, S. G. Taneva, and A. Cunningham, Ablation of the complementarity-determining region H3 apex of the anti-HIV1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding, J Virol, vol.84, issue.9, pp.4136-4183, 2010.

Z. Y. Sun, K. J. Oh, M. Kim, J. Yu, and V. Brusic, HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane, Immunity, vol.28, issue.1, pp.52-63, 2008.
DOI : 10.1016/j.immuni.2007.11.018
URL : https://doi.org/10.1016/j.immuni.2007.11.018

M. Kim, Z. Y. Sun, K. D. Rand, X. Shi, and L. Song, Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization, Nat Struct Mol Biol, vol.18, issue.11, pp.1235-1278, 2011.
DOI : 10.1038/nsmb.2154
URL : http://europepmc.org/articles/pmc3253551?pdf=render

J. Guenaga and R. T. Wyatt, Structure-guided Alterations of the gp41-directed HIV-1 Broadly Neutralizing Antibody 2F5 Reveal New Properties Regarding its Neutralizing Function, PLoS Pathog, vol.8, issue.7, p.1002806, 2012.
DOI : 10.1371/journal.ppat.1002806
URL : https://doi.org/10.1371/journal.ppat.1002806

M. Montero, N. Gulzar, K. A. Klaric, J. E. Donald, and C. Lepik, Neutralizing Epitopes in the Membrane-Proximal External Region of HIV-1 gp41 Are Influenced by the Transmembrane Domain and the Plasma Membrane, J Virol, vol.86, issue.6, pp.2930-2971, 2012.

B. K. Chakrabarti, L. M. Walker, J. F. Guenaga, A. Ghobbeh, and P. Poignard, Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity, J Virol, vol.85, issue.16, pp.8217-8243, 2011.
DOI : 10.1128/jvi.00756-11
URL : http://jvi.asm.org/content/85/16/8217.full.pdf

R. Rathinakumar, M. Dutta, P. Zhu, W. E. Johnson, and K. H. Roux, Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded andunliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions, J Virol, vol.86, issue.3, pp.1820-1851, 2012.

C. R. Ruprecht, A. Krarup, L. Reynell, A. M. Mann, and O. F. Brandenberg, MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1, J Exp Med, vol.208, issue.3, pp.439-54, 2011.
DOI : 10.1084/jem.20101907
URL : http://jem.rupress.org/content/208/3/439.full.pdf

J. S. Klein, P. N. Gnanapragasam, R. P. Galimidi, C. P. Foglesong, and A. P. West, Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10, Proc Natl Acad Sci, vol.106, issue.18, pp.7385-90, 2009.

G. Frey, H. Peng, S. Rits-volloch, M. Morelli, and Y. Cheng, A fusionintermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies, Proc Natl Acad Sci, vol.105, issue.10, pp.3739-3783, 2008.

M. A. Luftig, M. Mattu, D. Giovine, P. Geleziunas, R. Hrin et al., Structural basis for HIV-1 neutralization by a gp41 fusion intermediatedirected antibody, Nat Struct Mol Biol, vol.13, issue.8, pp.740-747, 2006.
DOI : 10.1038/nsmb1127

C. Sabin, D. Corti, V. Buzon, M. S. Seaman, L. Hulsik et al., Crystal structure and size-dependent neutralization properties of HK20, a human antibody binding to the highly conserved heptad repeat 1 of gp41, PLoS Pathogens, vol.6, issue.11, p.1001195, 2010.

E. Gustchina, M. Li, J. M. Louis, D. E. Anderson, and J. Lloyd, Structural basis of HIV-1 neutralization by affinity matured Fabs directed against the internal trimeric coiled-coil of gp41, PLoS Pathog, vol.6, issue.11, p.1001182, 2010.

X. Shen, R. J. Parks, D. C. Montefiori, J. L. Kirchherr, and B. F. Keele, In Vivo gp41 Antibodies Targeting the 2F5 Monoclonal Antibody Epitope Mediate Human Immunodeficiency Virus Type 1 Neutralization Breadth, J Virol, vol.83, issue.8, pp.3617-3625, 2009.

Z. Zhu, H. R. Qin, W. Chen, Q. Zhao, and X. Shen, Cross-reactive HIV1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies, J Virol, vol.85, issue.21, pp.11401-11409, 2011.
DOI : 10.1128/jvi.02726-13
URL : https://jvi.asm.org/content/87/24/13936.full.pdf

S. M. Alam, H. X. Liao, S. M. Dennison, F. Jaeger, and R. Parks, Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation, J Virol, vol.85, issue.22, pp.11725-11756, 2011.

L. Morris, X. Chen, M. Alam, G. Tomaras, and R. Zhang, Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting, PLoS One, vol.6, issue.9, p.23532, 2011.

S. M. Alam, R. M. Scearce, R. J. Parks, K. Plonk, and S. G. Plonk, Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection, J Virol, vol.82, issue.1, pp.115-140, 2008.

J. Pietzsch, J. F. Scheid, H. Mouquet, M. S. Seaman, and C. C. Broder, Antigp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity, J Virol, vol.84, issue.10, pp.5032-5074, 2010.
DOI : 10.1128/jvi.00154-10
URL : http://europepmc.org/articles/pmc2863839?pdf=render

H. X. Liao, X. Chen, S. Munshaw, R. Zhang, and D. J. Marshall, Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated, J Exp Med, vol.208, issue.11, pp.2237-2286, 2012.
DOI : 10.1084/jem.20110363
URL : http://jem.rupress.org/content/208/11/2237.full.pdf

L. Verkoczy, M. Diaz, T. M. Holl, Y. B. Ouyang, and H. Bouton-verville, Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance, Proc Natl Acad Sci, vol.107, issue.1, pp.181-187, 2010.

C. Hamers-casterman, T. Atarhouch, S. Muyldermans, G. Robinson, and C. Hamers, Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-454, 1993.

A. Forsman, E. Beirnaert, M. Aasa-chapman, B. Hoorelbeke, and K. Hijazi, Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120, J Virol, vol.82, issue.24, pp.12069-12081, 2008.
DOI : 10.1128/jvi.01379-08
URL : https://jvi.asm.org/content/82/24/12069.full.pdf

W. W. Koh, S. Steffensen, M. Gonzalez-pajuelo, B. Hoorelbeke, and A. Gorlani, Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1, J Biol Chem, vol.285, issue.25, pp.19116-19140, 2010.

S. Jahnichen, C. Blanchetot, D. Maussang, M. Gonzalez-pajuelo, and K. Y. Chow, CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells, Proc Natl Acad Sci, vol.107, issue.47, pp.20565-70, 2011.

A. Hinz, L. Hulsik, D. Forsman, A. Koh, W. W. Belrhali et al., Crystal structure of the neutralizing Llama V(HH) D7 and its mode of HIV-1 gp120 interaction, PLoS One, vol.5, issue.5, p.10482, 2010.

L. E. Mccoy, A. F. Quigley, N. M. Strokappe, B. Bulmer-thomas, and M. S. Seaman, Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization, J Exp Med, vol.209, issue.6, pp.1091-103, 2012.

N. Strokappe, A. Szynol, M. Aasa-chapman, A. Gorlani, F. Quigley et al., Llama antibody fragments recognizing various epitopes of the CD4bs neutralize a broad range of HIV-1 subtypes A, B and C, PLoS One, vol.7, issue.3, p.33298, 2012.

P. B. Harbury, T. Zhang, P. S. Kim, and T. Alber, A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants, Science, vol.262, issue.5138, pp.1401-1408, 1993.
DOI : 10.1126/science.8248779

H. J. De-haard, B. Kazemier, M. J. Koolen, L. J. Nijholt, and R. H. Meloen, Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics, Clin Diagn Lab Immunol, vol.5, issue.5, pp.636-680, 1998.

M. Pancera and R. Wyatt, Selective recognition of oligomeric HIV-1 primary isolate envelope glycoproteins by potently neutralizing ligands requires efficient precursor cleavage, Virology, vol.332, issue.1, pp.145-56, 2005.
DOI : 10.1016/j.virol.2004.10.042
URL : https://doi.org/10.1016/j.virol.2004.10.042

C. A. Derdeyn, J. M. Decker, J. N. Sfakianos, X. Wu, O. Brien et al., Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T20 is modulated by coreceptor specificity defined by the V3 loop of gp120, J Virol, vol.74, issue.18, pp.8358-67, 2000.

X. Wei, J. M. Decker, H. Liu, Z. Zhang, and R. B. Arani, Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy, Antimicrob Agents Chemother, vol.46, issue.6, pp.1896-905, 2002.

M. Li, F. Gao, J. R. Mascola, L. Stamatatos, and V. R. Polonis, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies, J Virol, vol.79, pp.10108-10133, 2005.
DOI : 10.1128/jvi.79.16.10108-10125.2005
URL : http://jvi.asm.org/content/79/16/10108.full.pdf

J. P. Langedijk, A. H. Brandenburg, W. G. Middel, A. Osterhaus, and R. H. Meloen, A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests, J Clin Microbiol, vol.35, issue.7, pp.1656-60, 1997.

J. W. Slootstra, W. C. Puijk, G. J. Ligtvoet, J. P. Langeveld, and R. H. Meloen, Structural aspects of antibody-antigen interaction revealed through small random peptide libraries, Mol Divers, vol.1, issue.2, pp.87-96, 1996.
DOI : 10.1007/bf01721323

T. G. Battye, L. Kontogiannis, O. Johnson, H. R. Powell, and A. G. Leslie, iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM, Acta Crystallogr D Biol Crystallogr, vol.67, pp.271-81, 2011.
DOI : 10.1107/s0907444910048675
URL : http://journals.iucr.org/d/issues/2011/04/00/ba5160/ba5160.pdf

P. Evans, Scaling and assessment of data quality, Acta Crystallogr D Biol Crystallogr, vol.62, pp.72-82, 2006.

A. J. Mccoy, R. W. Grosse-kunstleve, P. D. Adams, M. D. Winn, and L. C. Storoni, Phaser crystallographic software, J Appl Crystallogr, vol.40, pp.658-674, 2007.

A. Perrakis, R. Morris, and V. S. Lamzin, Automated protein model building combined with iterative structure refinement, Nat Struct Biol, vol.6, pp.458-463, 1999.

P. Emsley and K. Cowtan, Coot: model-building tools for molecular graphics, Acta Crystallogr D Biol Crystallogr, vol.60, pp.2126-2132, 2004.
DOI : 10.1107/s0907444904019158
URL : http://journals.iucr.org/d/issues/2004/12/01/ba5070/ba5070.pdf

G. N. Murshudov, A. A. Vagin, and E. J. Dodson, Refinement of macromolecular structures by the maximum-likelihood method, Acta Crystallogr D Biol Crystallogr, vol.53, pp.240-255, 1997.

A. Favier and B. Brutscher, Recovering lost magnetization: polarization enhancement in biomolecular NMR, J Biomol NMR, vol.49, issue.1, pp.9-15, 2010.
DOI : 10.1007/s10858-010-9461-5

F. Delaglio, S. Grzesiek, G. W. Vuister, and G. Zhu, NMRPipe: a multidimensional spectral processing system based on UNIX pipes, J Biomol NMR, vol.6, issue.3, pp.277-93, 1995.
DOI : 10.1007/bf00197809

W. F. Vranken, W. Boucher, T. J. Stevens, R. H. Fogh, and A. Pajon, The CCPN data model for NMR spectroscopy: development of a software pipeline, Proteins, vol.59, issue.4, pp.687-96, 2005.

J. L. Markley, A. Bax, Y. Arata, C. W. Hilbers, and R. Kaptein, Recommendations for the presentation of NMR structures of proteins and nucleic acids. IUPAC-IUBMB-IUPAB Inter-Union Task Group on the Standardization of Data Bases of Protein and Nucleic Acid Structures Determined by NMR Spectroscopy, J Biomol NMR, vol.12, issue.1, pp.1-23, 1998.

S. J. De-vries, M. Van-dijk, and A. M. Bonvin, The HADDOCK web server for data-driven biomolecular docking, Nat Protoc, vol.5, issue.5, pp.883-97, 2010.

A. T. Brunger, P. D. Adams, G. M. Clore, W. L. Delano, and P. Gros, Crystallography & NMR system: A new software suite for macromolecular structure determination, Acta Crystallogr D Biol Crystallogr, vol.54, pp.905-926, 1998.

M. Krzeminski, K. Loth, R. Boelens, and A. M. Bonvin, SAMPLEX: automatic mapping of perturbed and unperturbed regions of proteins and complexes, BMC Bioinformatics, vol.11, p.51, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00663535

Y. Shen, F. Delaglio, G. Cornilescu, and A. Bax, TALOS+: a hybrid method for predicting protein backbone torsion angles from NMR chemical shifts, J Biomol NMR, vol.44, issue.4, pp.213-236, 2009.
DOI : 10.1007/s10858-009-9333-z
URL : http://europepmc.org/articles/pmc2726990?pdf=render

J. Fernandez-recio, M. Totrov, and R. Abagyan, Identification of proteinprotein interaction sites from docking energy landscapes, J Mol Biol, vol.335, issue.3, pp.843-65, 2004.

B. Brugger, B. Glass, P. Haberkant, I. Leibrecht, and F. T. Wieland, The HIV lipidome: a raft with an unusual composition, Proc Natl Acad Sci, vol.103, issue.8, pp.2641-2647, 2006.
DOI : 10.1073/pnas.0511136103
URL : http://www.pnas.org/content/103/8/2641.full.pdf

J. P. Langedijk, M. J. Zekveld, M. Ruiter, D. Corti, and J. W. Back, Helical peptide arrays for lead identification and interaction site mapping, Anal Biochem, vol.417, issue.1, pp.149-55, 2011.
DOI : 10.1016/j.ab.2011.06.002

E. De-rosny, R. Vassell, S. Jiang, R. Kunert, and C. D. Weiss, Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes, J Virol, vol.78, issue.5, pp.2627-2658, 2004.

A. S. Dimitrov, A. Jacobs, C. M. Finnegan, G. Stiegler, H. Katinger et al., Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion, Biochemistry, vol.46, issue.5, pp.1398-401, 2007.

E. T. Crooks, T. Tong, K. Osawa, and J. M. Binley, Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected, J Virol, vol.85, issue.12, pp.5825-5864, 2011.
DOI : 10.1128/jvi.00154-11
URL : http://jvi.asm.org/content/85/12/5825.full.pdf

K. Hedestam, G. B. Fouchier, R. A. Phogat, S. Burton, D. R. Sodroski et al., The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus, Nat Rev Microbiol, vol.6, issue.2, pp.143-55, 2008.

G. Frey, J. Chen, S. Rits-volloch, M. M. Freeman, and S. Zolla-pazner, Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies, Nat Struct Mol Biol, vol.17, issue.12, pp.1486-91, 2010.
DOI : 10.1038/nsmb.1950
URL : http://europepmc.org/articles/pmc2997185?pdf=render

H. Mouquet, M. Warncke, J. F. Scheid, M. S. Seaman, and M. C. Nussenzweig, Enhanced HIV-1 neutralization by antibody heteroligation, Proc Natl Acad Sci, vol.109, issue.3, pp.875-80, 2012.
DOI : 10.1073/pnas.1120059109
URL : http://www.pnas.org/content/109/3/875.full.pdf

S. M. Alam, M. Mcadams, D. Boren, M. Rak, R. M. Scearce et al., The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes, J Immunol, vol.178, issue.7, pp.4424-4459, 2007.

S. Sanchez-martinez, M. Lorizate, H. Katinger, R. Kunert, and J. L. Nieva, Membrane association and epitope recognition by HIV-1 neutralizing antigp41 2F5 and 4E10 antibodies, AIDS Res Hum Retroviruses, vol.22, issue.10, pp.998-1006, 2006.

L. Song, Z. Y. Sun, K. E. Coleman, M. B. Zwick, and J. S. Gach, Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface, Proc Natl Acad Sci, vol.106, issue.22, pp.9057-62, 2009.

T. Zhou, I. Georgiev, X. Wu, Z. Y. Yang, and K. Dai, Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01, Science, vol.329, issue.5993, pp.811-818, 2010.
DOI : 10.1126/science.1192819
URL : http://europepmc.org/articles/pmc2981354?pdf=render

N. I. Nicely, S. M. Dennison, L. Spicer, R. M. Scearce, and G. Kelsoe, Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membraneproximal external region, Nat Struct Mol Biol, vol.17, issue.12, pp.1492-1496, 2010.

P. Timmerman, J. Beld, W. C. Puijk, and R. H. Meloen, Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces, Chembiochem, vol.6, issue.5, pp.821-825, 2005.

J. R. Mascola, D. Souza, P. Gilbert, P. Hahn, B. H. Haigwood et al., Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines, J Virol, vol.79, issue.16, pp.10103-10110, 2005.